In a potentially transformative move for healthcare, the NHS is rolling out an “artificial pancreas” for people suffering from type 1 diabetes. Known as the Hybrid Closed Loop (HCL) system, the artificial pancreas is a device that significantly automates the management of blood sugar and insulin levels — a necessary process for those living with the condition. Specifically, the device continuously monitors blood sugar (glucose) levels, determines the amount of insulin needed, and transmits this information to a pump. This way, patients don’t need to constantly monitor themselves with finger prick blood tests or by wearing a traditional glucose monitor.…

This story continues at The Next Web